Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Allison Fedolak"'
Autor:
Iain M. Wallace, Hyun-Hee Cho, Pramod Pandey, Soo-Hee Park, Allison Fedolak, Dechristopher Brian Addison, Christopher Hogan, Olga Rozhitskaya, Derek Bamford, Liansheng Su, Toshiyuki Honda, Rohit Duvadie, Linh Vong, Elizabeth Tomlinson
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 29:991-994
The relaxin family peptide receptors have been implicated in numerous physiological processes including energy homeostasis, cardiac function, wound healing, and reproductive function. Two family members, RXFP3 and RXFP4, are class A GPCRs with endoge
Autor:
Allison Fedolak, Vassilios Papadopoulos, Irina N. Gaisina, Andrew Midzak, Emily Sabath, Taleen Hanania, Dani Brunner, Hendra Gunosewoyo, Alan P. Kozikowski
Publikováno v:
Journal of Medicinal Chemistry. 56:5115-5129
Inhibition of GSK-3β has been well documented to account for the behavioral actions of the mood stabilizer lithium in various animal models of mood disorders. Recent studies have showed that genetic or pharmacological inhibition of GSK-3β resulted
Autor:
Oluseye K. Onajole, Dani Brunner, J. Brek Eaton, Li-Fang Yu, Allison Fedolak, Hendra Gunosewoyo, Han Kun Zhang, Ronald J. Lukas, Alan P. Kozikowski
We previously reported the cyclopropylpyridine and isoxazolylpyridine ether scaffolds to be versatile building blocks for creating potent α4β2 nicotinic acetylcholine receptor (nAChR) partial agonists with excellent selectivity over the α3β4 subt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c3a9f05eefcc149a307e2923ae03bd8
https://europepmc.org/articles/PMC5097879/
https://europepmc.org/articles/PMC5097879/
Autor:
Dani Brunner, Barbara J. Caldarone, Allison Fedolak, Ronald J. Lukas, Taleen Hanania, J. Brek Eaton, Werner Tückmantel, Li-Fang Yu, Alan P. Kozikowski
Publikováno v:
Journal of Medicinal Chemistry. 55:812-823
There is considerable evidence to support the hypothesis that the blockade of nAChR is responsible for the antidepressant action of nicotinic ligands. The nicotinic acetylcholine receptor (nAChR) antagonist, mecamylamine, has been shown to be an effe
Autor:
Katie Cavino, Afshin Ghavami, Barbara J. Caldarone, Jianhua Liu, Allison Fedolak, Li-Fang Yu, Ronald J. Lukas, Christina Ruiz, Alan P. Kozikowski, Matthew Terry, Daguang Wang, David Lowe, Dani Brunner, J. Brek Eaton
Publikováno v:
Journal of Medicinal Chemistry. 54:7280-7288
Depression, a common neurological condition, is one of the leading causes of disability and suicide worldwide. Standard treatment, targeting monoamine transporters selective for the neurotransmitters serotonin and noradrenaline, is not able to help m
Autor:
Allison Fedolak, Michael Manzano, Marina R. Picciotto, Afshin Ghavami, Mei Kwan, Berend Olivier, Sheela K. Chellappan, Daguang Wang, Taleen Hanania, Katie Cavino, Neil E. Paterson, Barbara J. Caldarone, Alan P. Kozikowski
Publikováno v:
Psychopharmacology. 217:199-210
Nicotinic acetylcholine receptor (nAChR) agonists, partial agonists, and antagonists have antidepressant-like effects in rodents and reduce symptoms of depression in humans.The study determined whether the antidepressant-like effect of the nAChR β2*
Autor:
Berend Olivier, Barbara J. Caldarone, Allison Fedolak, Neil E. Paterson, Taleen Hanania, Afshin Ghavami
Publikováno v:
Pharmacology Biochemistry and Behavior. 95:449-456
The present studies assessed the potential abuse liability and likely mechanism(s) of action of the wake-promoting agent modafinil. Methods Experiments assessed the locomotor sensitization (LS) and discriminative stimulus (DS) properties of modafinil
Autor:
Han Kun Zhang, Taleen Hanania, Ronald J. Lukas, J. Brek Eaton, Alan P. Kozikowski, Li-Fang Yu, Allison Fedolak, Dani Brunner
Publikováno v:
Journal of medicinal chemistry. 55(22)
In our continued efforts to develop α4β2-nicotinic acetylcholine receptor (nAChR) partial agonists as novel antidepressants having a unique mechanism of action, structure-activity relationship (SAR) exploration of certain isoxazolylpyridine ethers
Autor:
Irina N. Gaisina, Sylvie Y. Blond, Hongbin Yuan, Alan P. Kozikowski, Barbara J. Caldarone, Allison Fedolak, Pavel A. Petukhov, Paul McGonigle
Publikováno v:
Journal of the American Chemical Society. 129(26)
More than two million American adults, or approximately one percent of the population 18 years or older, suffer from bipolar disorder. Current treatments include the so-called "mood stabilizers," lithium and valproic acid. Both are relatively dated d
Autor:
Jianhua Liu, Li-Fang Yu, J. Brek Eaton, Barbara Caldarone, Katie Cavino, Christina Ruiz, Matthew Terry, Allison Fedolak, Daguang Wang, Afshin Ghavami, David A. Lowe, Dani Brunner, Ronald J. Lukas, Alan P. Kozikowski
Publikováno v:
Journal of Medicinal Chemistry; Oct2011, Vol. 54 Issue 20, p7280-7288, 9p